Table 4 Patients' satisfaction rate of the treatment during 3, 6, and 12 months follow-up in both study groups
Group I (N = 85) | Group II (N = 86) | P value | |||||
|---|---|---|---|---|---|---|---|
3MS | 6MS | 12MS | 3MS | 6MS | 12MS | ||
Excellent | 19/85 (22.35%) | 17/85 (20%) | 17/85 (20%) | 20/86 (23.25%) | 19/86 (22.09%) | 19/86 (22.09%) | NS |
Good | 26/85 (30.58 %) | 24/85 (28.23%) | 22/85 (25.88%) | 25/86 (29.06%) | 23/86 (26.74 %) | 22/86 (23.25 %) | NS |
Moderate | 18/85 (21.17%) | 22/85 (25.88%) | 22/85 (25.88%) | 20/86 (23.86 %) | 23/86 (26.74%) | 21/86 (24.41%) | NS |
No improvement | 22/85 (25.88%) | 22/85 (25.88%) | 24/85 (28.23%) | 21/86 (24.41%) | 21/86 (24.41%) | 24/86 (27.90%) | NS |
aCumulative satisfaction rate | 63/85 (74.11%) | 63/85 (74.11%) | 61/85 (71.76%) | 65/86 (75.58%) | 65/86 (75.58%) | 62/86 (72.09%) | NS |